Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_assertion evidence source_evidence_literature NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_assertion SIO_000772 19489767 NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_assertion wasDerivedFrom befree-20150227 NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_assertion wasGeneratedBy ECO_0000203 NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP445112.RA2xtX5GHDnkCMC7aQn2UMBgmNcJy1whfO8PTolQ58AU4130_provenance.